C Coban - Current opinion in immunology, 2020 - Elsevier
Highlights•Chloroquine/hydroxychloroquine is an old anti-malarial drug belongs to 4- aminoquinolines.•Chloroquine has additional anti-virus, anti-bacteria, anti-protozoan, anti …
Malaria caused by Plasmodium affects millions people worldwide. Plasmodium consumes hemoglobin during its intraerythrocytic stage leaving toxic heme. Parasite detoxifies free …
S Kamat, M Kumari - Frontiers in Pharmacology, 2021 - frontiersin.org
Chloroquine and its derivatives have been used since ages to treat malaria and have also been approved by the FDA to treat autoimmune diseases. The drug employs pH-dependent …
The development of parasite resistance to first-line antimalarial medicines, especially the Artemisinin-based combination therapies (ACTs), has made the research and development …
N Simon, C Voigtländer, B Kappes, P Rohrbach… - Pharmaceuticals, 2022 - mdpi.com
Drug resistance often emerges from mutations in solute transporters. Single amino acid exchanges may alter functionality of transporters with 'de novo'ability to transport drugs away …
BJ Sawyer, MIH Khan, HV Le - Medicinal Chemistry of Chemotherapeutic …, 2023 - Elsevier
Malaria is a mosquito-borne infectious disease that remains one of the world's most frequent causes of morbidity and mortality. According to the World Malaria Report 2021, published by …
Background Chloroquine (CQ) was the drug of choice for decades in the treatment of falciparum malaria until resistance emerged. CQ is suggested to accumulate in the …
Identification of new druggable protein targets remains the key challenge in the current antimalarial development efforts. Here we used mass-spectrometry-based cellular thermal …
L Vargas-Jaimes, MC Rodriguez… - International Journal of …, 2021 - Springer
Malaria is a parasitic disease, caused by protozoa of the genus Plasmodium, and is transmitted to humans through the bites of infected Anopheles mosquitoes. More than 200 …